Introduction: Autoimmune bullous diseases (AIBD) are a heterogeneous group of rare autoantibody-mediated blistering dermatoses of the skin and/or mucous membranes. Their incidence is around 20 new cases per million inhabitants per year in Germany. Patients with chronic, oncological, or rare diseases often urge for a holistic therapeutic approach that includes complementary and alternative medicine (CAM). So far, only few contradictory reports on CAM in pemphigoid or pemphigus disease exist. The purpose of this study was to determine the frequency, motives, and satisfaction with the use of alternative treatments in patients with AIBD and to provide a basis for further investigation. Methods: We used a structured online questionnaire, consisting of 20 questions to survey patients with AIBD and their relatives. The German pemphigus and pemphigoid self-help groups were responsible for distributing anonymized questionnaires. In total, we recovered 97 questionnaires, 63 of which met full inclusion criteria (24 males and 39 females). Results: Of the included participants, more than half had a currently active disease. Of all patients, 58.7% stated that they had used CAM at least once. Women were more likely to use CAM, whereas age and education showed no association to CAM use. The main motives for using CAM were “doing something for oneself” and “opportunity to contribute to treatment” (38.1% each). The internet (23.8%) was the most common source of information, and vitamins were the most frequently used therapy (49.2%). Conclusion: Our results provide new insights into the demand for CAM within this rare disease patient group. Physicians should be aware of these methods to meet patient needs but also be able to identify potential barriers such as risks and interactions.

Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, et al. S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2020 Mai;18(5):516–27.
van Beek N, Zillikens D, Schmidt E. Bullous Autoimmune Dermatoses. Deutsches Ärzteblatt international. Dtsch Arztebl Int. 2021 Juni 18;118:413–20 [zitiert 7. August 2022]; Verfügbar unter:
Gudat W, Nürnberg W. [Holistic approach to in-patient dermatological rehabilitation]. Hautarzt. 2010 Apr;61(4):310–6.
Ansorge C, Miocic JM, Schauer F. Skin diseases in hospitalized geriatrics: a 9-year analysis from a university dermatology center in Germany. Arch Dermatol Res. 2022 Juni;314(5):427–37.
Bardazzi F, Filippi F, Chessa MA, Iommi M, Loi C, Campanati A, et al. Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study. J Eur Acad Dermatol Venereol. 2022 Juli;36(12):2473–81.
Ernst E. The role of complementary and alternative medicine. BMJ. 2000 Nov;321(7269):1133–5.
Cholera M, Chainani-Wu N. Management of pemphigus vulgaris. Adv Ther. 2016 Juni;33(6):910–58.
National Center for Complementary and Integrative Health [Internet]. [Internet]. Complementary, Alternative, or Integrative Health: What’s In a Name? 2021. Verfügbar unter:
Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, et al. Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer. 2017 Januar;71:70–9.
Hasan SS, Ahmed SI, Bukhari NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009 August;15(3):152–7.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.
Huebner J, Mohr P, Simon JC, Fluck M, Berking C, Zimmer L, et al. Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial: complementary medicine and melanoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2016 Mai;14(5):508–13.
Pemphigus und Pemphigoid Selbsthilfegruppe [Internet]: [Internet]. Verfügbar unter:
Ernst E, Pittler MH, Stevinson C. Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments. Am J Clin Dermatol. 2002;3(5):341–8.
Gotta M, Mayer CA, Huebner J. Use of complementary and alternative medicine in patients with multiple sclerosis in Germany. Complement Ther Med. 2018 Februar;36:113–7.
Verma S, Thuluvath PJ. Complementary and alternative medicine in hepatology: review of the evidence of efficacy. Clin Gastroenterol Hepatol. 2007;5(4):408–16.
Chowdhuri PD, Kundu K. Factors determining choice of complementary and alternative medicine in acute and chronic diseases. J Complement Integr Med. 2020 Oktober;17(3):20190105.
Mayrshofer F, Hertl M, Sinkgraven R, Sticherling M, Pfeiffer C, Zillikens D, et al. Significant decrease in quality of life in patients with pemphigus vulgaris: results from the German Bullous Skin Disease (BSD) study group. J Deut Dermatol Gesell. 2005 Juni;3(6):431–5.
Feliciani C, Joly P, Jonkman MF, Zambruno G, Zillikens D, Ioannides D, et al. Management of bullous pemphigoid: the European dermatology forum consensus in collaboration with the European academy of dermatology and venereology. Br J Dermatol. 2015;172(4):867–77.
Rommel A, Nübel J, Kroll LE, Prütz F, Thom J. The utilization of psychiatric and psychotherapeutic services in Germany: individual determinants and regional differences. Journal of Health Monitoring. 2017 Dezember;152:3–21.
Josfeld L, Krüger L, Büntzel J, Zomorodbakhsch B, Hübner J. Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology. J Cancer Res Clin Oncol. 2022 Oktober;148(10):2707–15.
Rhee SM, Garg VK, Hershey CO. Use of complementary and alternative medicines by ambulatory patients. Arch Intern Med. 2004 Mai;164(9):1004–9.
Simpson EL, Basco M, Hanifin J. A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat. 2003;14(3):144–7.
Burke A, Nahin RL, Stussman BJ. Limited health knowledge as a reason for non-use of four common complementary health practices. PLoS One. 2015 Juni;10(6):e0129336.
Kessel KA, Lettner S, Kessel C, Bier H, Biedermann T, Friess H, et al. Use of complementary and alternative medicine (CAM) as part of the oncological treatment: survey about patients’ attitude towards CAM in a university-based oncology center in Germany. PLoS One. 2016;11(11):e0165801.
Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006 Dezember;12(6):467–74.
Gressel Raz O, Samuels N, Levy M, Leviov M, Lavie O, Ben-Arye E. Association between physical activity and use of complementary medicine by female oncology patients in an integrative palliative care setting. J Altern Complement Med. 2020 Aug;126(8):721–8.
Gamret AC, Price A, Fertig RM, Lev-Tov H, Nichols AJ. Complementary and alternative medicine therapies for psoriasis: a systematic review. JAMA Dermatol. 2018;154(11):1330–7.
Bodeker G, Ryan TJ, Volk A, Harris J, Burford G. Integrative skin care: dermatology and traditional and complementary medicine. J Altern Complement Med. 2017 Juni;23(6):479–86.
Vieira BL, Lim NR, Lohman ME, Lio PA. Complementary and alternative medicine for atopic dermatitis: an evidence-based review. Am J Clin Dermatol. 2016 Dezember;17(6):557–81.
Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70(5):421–4.
Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, et al. S2k guideline on diagnosis and treatment of atopic dermatitis-short version. J Dtsch Dermatol Ges. 2016 Januar;14(1):92–106.
White AR, Ernst E. Economic analysis of complementary medicine: a systematic review. Complement Ther Med. 2000 Juni;8(2):111–8.
Bax CE, Chakka S, Concha JSS, Zeidi M, Werth VP. The effects of immunostimulatory herbal supplements on autoimmune skin diseases. J Am Acad Dermatol. 2021;84(4):1051–8.
Ruocco V, Brenner S, Lombardi ML. A case of diet-related pemphigus. Dermatology. 1996;192(4):373–4.
Borrelli F, Capasso R, Izzo AA. Garlic (Allium sativum L): adverse effects and drug interactions in humans. Mol Nutr Food Res. 2007;51(11):1386–97.
Ge XL, Li SZ, Jin X, Jin HZ, Zuo YG. Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F. Dermatol Ther. 2020 Juli;33(4):e13721.
Ventura MT, Viola M, Calogiuri G, Gaeta F, Pesole O, Romano A. Hypersensitivity reactions to complementary and alternative medicine products. Curr Pharm Des. 2006 Februar;12(26):3393–9.
Simpson EL, Law SV, Storrs FJ. Prevalence of botanical extract allergy in patients with contact dermatitis. Dermatitis. 2004 Juni;15(2):67–72.
Golsch S, Vocks E, Rakoski J, Brockow K, Ring J. [Reversible increase in photosensitivity to UV-B caused by St. John’s wort extract]. Hautarzt. 1997;48(4):249–52.
Lai YC, Yew YW, Lambert WC. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2016 Dezember;30(12):2007–15.
Herbs and Supplements: MedlinePlus [Internet] [Internet]. Verfügbar unter:
Corbin Winslow L, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med. 2002 Mai;162(10):1176–81.
Trimborn A, Senf B, Muenstedt K, Buentzel J, Micke O, Muecke R, et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol. 2013 Oktober;24(10):2641–5.
You do not currently have access to this content.